The goal of the study was to investigate the relationships between coronary artery disease (CAD) and risk factors, including the serum levels of high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) (Lp(a)) and homocysteine, in Japanese patients with peripheral arterial disease (PAD).
Introduction
Coronary artery disease (CAD) is closely associated with peripheral arterial disease (PAD) and a major cause of death in patients with PAD 1-3) . Patients with PAD also frequently develop diabetes or hyperlipidemia and may have extensive and severe systemic The serum level of hs-CRP is also an independent risk factor for cardiovascular disease, regardless of the LDLcholesterol level [7] [8] [9] . Lipoprotein(a) (Lp(a)) has a high degree of homology with plasminogen and is also a risk factor for cardiovascular disease 10, 11) . Lp(a) is involved in the adhesion of inflammatory cells and migration and uptake of macrophage foam cells into the arterial wall 12) , and the Lp(a) level is positively associated with CAD events 13) . Homocysteine is an intermediate metabolite of methionine that contributes to cardiovascular disease via mechanisms such as endothelial dysfunction, increased lipid permeability and vascular inflammation 14, 15) . Hyperhomocysteinemia is an independent risk factor for PAD and CAD 16, 17) . Hence, the combination of high homocysteine and Lp(a) levels synergistically increases the likelihood of developing CAD 15) .
The roles of the serum hs-CRP, Lp(a) and homocysteine levels as potential risk factors for CAD are not fully understood in Japanese patients with PAD. Therefore, the purpose of the present study was to examine the risk factors and prevalence of CAD in this population.
Patients and Methods

Patients
The study cohort consisted of 451 consecutive patients referred to the Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital) between January 1st, 2009 and December 31st, 2013. Written consent to participate in this study was obtained from all patients, and the study protocol was approved by our institutional ethics committee before the initiation of the study. All patients had an ankle brachial pressure index (ABI) of ＜0.90 at their first visit and were diagnosed with PAD based on clinical symptoms and iliac or femoropopliteal artery stenosis of ≥ 70% on angiography. The clinical stages of PAD and critical limb ischemia (CLI) and the Fontaine stage were classified according to the TASC-II criteria 1) . ABI was determined in all subjects using the ABI-form (Colin, Tokyo, Japan), which simultaneously measures the bilateral arm and ankle blood pres-The prevalence of diabetes was higher among the patients with CAD than among those without. The mean age, ABI, body mass index and prevalence of CLI did not differ significantly between the two groups. The levels of hs-CRP, Lp(a) and homocysteine were higher in the patients with CAD, whereas the eGFR and HDL cholesterol values were lower in these patients. In contrast, the levels of brain natriuretic peptide and fibrinogen were not significantly different between the two groups. Meanwhile, there were no significant differences in medical treatment between the two groups, although the frequency of statin or antiplatelet therapy exhibited a tendency to be higher in the patients with CAD.
Prevalence of CAD
The results of CAG are summarized in Fig. 1 . The prevalence of coronary artery stenosis with ≥ 70% LD narrowing was 50.1%, while that of coronary artery stenosis with ≥ 70% LD narrowing or a history of treatment for CAD was 55.9%. The prevalence of coronary artery stenosis with ≥ 50% LD narrowing was 74.1%. The rate of coronary artery stenosis (≥ 70%) with single-, double-and triple-vessel disease, including left main artery disease, was 25.9%, 13.5% and 10.6%, respectively. The prevalence of CAD was 57.4%, 56.2%, 34.6% and 57.8% in Fontaine stages I, II, III and IV, respectively, with no significant differences between the stages (p = 0.165).
Risk Factors for CAD
According to the univariate logistic analysis, CAD was significantly related to diabetes, eGFR, hs-CRP, HDL cholesterol, triglyceride, Lp(a) and homocysteine. In the multiple logistic analysis, CAD was found to be significantly associated with diabetes, hs-CRP, Lp(a) and homocysteine and showed a tendency toward an association with triglycerides and a low HDL cholesterol level ( Table 2 ). The number of stenotic coronary arteries demonstrated simple correlations with diabetes, smoking, eGFR, HDL-cholesterol, LDL-cholesterol and D-dimer (p＜0.05). In the stepwise multiple regression analysis, diabetes, D-dimer and LDL-cholesterol displayed significant positive relationships with the number of stenotic coronary arteries ( Table 3 ). The sum of the three coronary artery stenotic rates in each segment was also significantly related to LDL-cholesterol, diabetes and D-dimer in the stepwise multiple regression analysis.
Lp(a) had simple correlations with LDL-cholesterol, fibrinogen and body mass index (BMI) (p＜ 0.05). The stepwise forward multiple regression analysis of the relationship of these factors with Lp(a) cigarettes/day. Alcohol intake was defined as an average consumption of ＞10 g/day of absolute alcohol for ＞1 year within the past five years.
Assessment of PAD and CAD
Peripheral lesions were evaluated using digital subtraction angiography. Left and right coronary angiography (CAG) and left ventriculography were performed before abdominal and peripheral angiography. CAG was recorded at 25 frames/second. The luminal diameter (LD) was measured at end-diastole via quantitative coronary angiography using the automatic software program provided by the manufacturer (Philips Med, Best, The Netherlands). In cases involving stenotic coronary arteries, changes in the LD of stenosis were analyzed separately from the changes in the adjacent reference segments. The prevalence of CAD was defined as coronary artery stenosis with ≥ 70% LD narrowing or a history of treatment for CAD, defined as revascularization via percutaneous coronary intervention or coronary artery bypass surgery and/or the use of medical treatment after CAG.
Statistical Analysis
Continuous variables are expressed as medians (interquartile range) and were compared using the Wilcoxon test. Categorical variables are expressed as numbers (%) and were compared using the chi-square test. Odds ratios (ORs) and confidence intervals (CIs) were calculated for individual risk factors in a univariate logistic analysis. Factors with a p value of ＜0.05 in the univariate analysis were evaluated in a multivariate logistic analysis to detect predictors of CAD. In the multiple regression analysis, simple Pearson correlations were calculated for all risk factors, including medical treatment, the number of affected coronary arteries and the Lp(a), homocysteine and hs-CRP levels. Factors with a p value of ＜0.05 in the correlation analysis were evaluated using a stepwise forward multiple regression analysis to examine the relationships between individual risk factors and the number of affected coronary arteries, Lp(a), homocysteine and hs-CRP. The SPSS v. 17.0 (SPSS Inc., Chicago, IL) software program was used for all calculations, and a p value of ＜0.05 was considered to be significant.
Results
Patient Characteristics
The subjects included 451 patients with PAD who underwent CAG. The median age was 72 (65 to 77) years. The clinical characteristics, including comorbidities and risk factors, are summarized in Table 1 .
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Discussion
In this study, the rate of a history of CAD was 21.1%, while the prevalence of CAD and coronary artery stenosis (≥ 50%) was 55.9% and 74.1%, respectively, on CAG. TASC-II reports that half of patients with PAD have concomitant CAD 1) , and the baseline data in the REduction of Atherothrombosis for Continued Health (REACH) registry indicate that 25.5% and 29.7% of PAD patients have a history of acute myocardial infarction (AMI) and stable angina, respectively, worldwide 20) . Among the Japanese population in the REACH registry, 27.8% of the PAD patients had a history of CAD 21) , and Hirose et al. found a prevalence of concomitant CAD of 55% in Japanese patients with PAD using pharmacologic stress singlephoton emission computed tomography 22) . The present data confirm the high prevalence of asymptomatic CAD in patients with PAD. This finding is of importance because asymptomatic CAD is a precursor to symptomatic angina and/or AMI. Moreover, the prevalence of CAD did not differ among the Fontaine stages in this study, which indicates a poor prognosis for patients with PAD 1, 2) . revealed significant positive correlations with LDLcholesterol and fibrinogen and a significant negative correlation with BMI ( Table 4A ). The homocysteine level exhibited simple positive correlations with diabetes, HbA1c and brain natriuretic peptide and negative correlations with age, HDL-cholesterol and eGFR (p＜ 0.05). The stepwise forward multiple regression analysis of the relationship of homocysteine with these factors showed significant negative correlations with eGFR and age ( Table 4B ). The hs-CRP level displayed simple positive correlations with CLI, fibrinogen and D-dimer (p＜0.05). In the stepwise forward multiple regression analysis, fibrinogen and D-dimer were found to have significant positive relationships with hs-CRP ( Table 4C) .
The clinical characteristics of the patients who did and did not receive statin therapy are summarized in Table 5 . The patients treated with statins were younger and more frequently had diabetes and a history of CAD compared to those who did not receive statins, whereas CLI and current or former CAD were less frequent in this group. Meanwhile, BMI, eGFR and the serum levels of albumin, total cholesterol, RLP cholesterol and triglycerides were higher in the patients treated with statins, whereas the serum levels of homocysteine, D-dimer, TAT and PIC were lower in these patients. The prevalence of aspirin, clopido- tion, the fibrinogen level is particularly associated with the severity and potential for the further development of PAD 26) and functions as an independent risk factor for CAD 25) . Hyperhomocysteinemia is an independent risk factor for atherosclerosis and a stronger risk factor for PAD than for CAD 16, 17) , with an association with death or severe vascular events in patients with PAD 27) . We previously found that a high plasma homocysteine level is also a risk factor for CLI as well as PAD 17) . Furthermore, Masuda et al. 28) showed that diabetic subjects have higher homocysteine levels and that homocysteine has significant relationships with eGFR, Our results provide the first evidence that hs-CRP, Lp(a) and homocysteine are independent risk factors for concomitant CAD in Japanese patients with PAD. Chronic inflammation is an important risk factor for CAD and PAD 4-6) , and elevated hs-CRP levels are associated with limb amputation and all-cause mortality after endovascular treatment in hemodialysis patients with PAD 23) . Moreover, Seo et al. found a significant relationship between the level of hs-CRP and the risk of CAD 7) , and the serum level of hs-CRP is an independent risk factor for cardiovascular disease, regardless of the LDL-cholesterol level 7-9) . Our results confirm these findings in that an elevated hs-CRP level was found to be associated with an increased risk of CAD in Japanese patients with PAD.
We also demonstrated that CAD is similarly associated with diabetes, Lp(a) and homocysteine and exhibits a tendency toward an association with triglycerides and a low HDL cholesterol level. Lp(a) possesses a high degree of homology with plasminogen and is a known risk factor for cardiovascular disease 10, 11) . In addition, Lp(a) is involved in inflammatory cell adhesion and migration as well as the uptake of macrophage foam cells into the arterial wall and inactivation of tissue-factor pathway inhibitors 12) . Moreover, the Lp(a) levels are positively associated with CAD events, with a stepwise increase in the risk of AMI in association with an increasing level of Lp(a) without evidence of a threshold effect in the Copenhagen City Heart Study 13) . The Lp(a) level is also a reported risk factor for CAD in Japanese patients with type II diabetes 24) . In the current study, the Lp(a) level demonstrated significant positive correlations with LDL-cholesterol and fibrinogen and significant negative correlations with BMI. Fibrinogen is a precursor of fibrin formation and activates platelet aggregation with increasing plasma viscosity 25) ; it is also an acute-phase reactant that is increased in an inflammatory state 25) . In addi- 
